Xenon Pharmaceuticals (XENE) Current Leases (2019 - 2026)
Xenon Pharmaceuticals (XENE) reported Current Leases of $1.6 million for Q1 2026, up 12.95% year-over-year from $1.4 million in Q1 2025, and up 1.89% quarter-over-quarter from $1.5 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Current Leases (2019 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 8 years of Current Leases data on file, last reported at $1.6 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.6 million, up 12.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 12.95% YoY), and the FY2025 annual result was $1.5 million, up 11.91% from the prior year.
- Current Leases rose to $1.6 million in Q1 2026 per XENE's latest filing, from $1.5 million in the prior quarter.
- Over five years, Current Leases peaked at $1.6 million in Q1 2026 and troughed at $488000.0 in Q4 2022.
- A 5-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases decreased 19.34% in 2022, then jumped 166.19% in 2023.
- A 5-year view of Current Leases shows it stood at $488000.0 in 2022, then jumped by 166.19% to $1.3 million in 2023, then increased by 5.39% to $1.4 million in 2024, then climbed by 11.91% to $1.5 million in 2025, then gained by 1.89% to $1.6 million in 2026.
- Business Quant data shows XENE's Current Leases at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 488,000.00 |
| Dec 31, 2021 | 605,000.00 |
| Sep 30, 2021 | 686,000.00 |
| Jun 30, 2021 | 759,000.00 |
| Mar 31, 2021 | 270,000.00 |
| Dec 31, 2020 | 265,000.00 |
| Sep 30, 2020 | 596,000.00 |